Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 1/20 | 0.33 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.33 |
| ▸ | PDE4A | P27815 | 1/20 | 0.31 |
| ▸ | PDE4B | Q07343 | 1/20 | 0.31 |
| ▸ | PDE4C | Q08493 | 1/20 | 0.31 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | DDR1 | Q08345 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31322673 | 0.82 | IMPDH2 (0.32) | CYP4F2CYP4A11PDE4APDE4BPDE4C | |
| SCHEMBL16065518 | 0.73 | CA12 (0.39) | LMNA | |
| SCHEMBL24458088 | 0.72 | SHBG (0.36) | CYP4F2CYP4A11PDE4APDE4BPDE4C | |
| SCHEMBL29518822 | 0.72 | RIPK1 (0.44) | CYP4F2CYP4A11PDE4APDE4BPDE4C | |
| SCHEMBL698821 | 0.72 | RIPK1 (0.44) | CYP4F2CYP4A11PDE4APDE4BPDE4C | |
| SCHEMBL25612486 | 0.71 | POLB (0.42) | LMNA | |
| SCHEMBL7802421 | 0.69 | PDE4A (0.50) | CYP4F2CYP4A11PDE4APDE4BPDE4C | |
| SCHEMBL332293 | 0.68 | GAA (0.33) | CYP4F2CYP4A11PDE4APDE4BPDE4C | |
| SCHEMBL31322728 | 0.67 | — | — | |
| SCHEMBL1057960 | 0.66 | KDM4E (0.43) | CYP4F2CYP4A11PDE4APDE4BPDE4C |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025038462-A2 | INHIBITORS OF RNA HELICASE DHX9 AND USES THEREOF | ACCENT THERAPEUTICS, INC. (US) | 2025-02-20 | — | — | WO | disclosed |